Precision Medicine

HIMSS, AHIMA, AMIA all say the drastic cuts to ONC and other agencies will hamper patient safety and new cures, send innovation in a downward spiral and slow down work toward a learning health system.

In this podcast, we will review some of the ideas we shared in our previous podcasts on this series. We will also provide insights into what is new, what is driving the most current state of change and what we see as the next potential drivers.

Today’s IT infrastructures are not hearty enough to support the data needs of genomics and other emerging healthcare practices and capabilities,  HIMSS Analytics says.

While healthcare is not applying the same kind of data understanding that other service rely on, precision medicine will bring that to the fore, expert says.

CRISPR has sparked considerable excitement for precision medicine, but patient safety, enzyme delivery and today’s level of disease understanding are limiting mainstream adoption.

An ambitious project aims to provide insight on “the most diverse collection of people in human history.”

[Also: Politico uncovers more funding indiscretions from Patrick Soon-Shiong]Despite company losing $41 million in the first quarter, biotech mogul Patrick Soon-Shiong defended his company’s work and chastised what he called false reports.

New cancer test requires less DNA than previous versions.

Emails reveal details of the strings attached to Patrick Soon-Shiong’s $12 million donation to the University of Utah.

A deep dive into the features healthcare organizations need, obstacles to avoid, and insights from executives who have already made the move to population health management.